Merck Completes Enrolment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021

  • Deirdre Bennett

Press/Media

Period5 Oct 2021

Media coverage

1

Media coverage

  • TitleMerck Completes Enrolment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021
    Media name/outletUAE Business Review
    Country/TerritoryUnited Arab Emirates
    Date5/10/21
    URLwww.uaereview.com/story-z16859089
    PersonsDeirdre Bennett
View all 1
View less